3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
5
Venous Thrombosis
4
Venous Thromboembolism
1
Thrombosis
1
Thromboembolism
1
Pulmonary Embolism
1
Myeloproliferative Disorders
1
Hemostatic Disorders
1
Interventions
apixaban
17
Dalteparin
12
Rivaroxaban
11
Heparin, Low-Molecular-Weight
8
Enoxaparin
8
Aspirin
8
Tinzaparin
6
Nadroparin
3
Fondaparinux
3
Warfarin
2
Rosuvastatin Calcium
2
Observation
2
Dabigatran
2
sotorasib
1
ribociclib
1
reviparin
1
palbociclib
1
enoxaparin sodium
1
edoxaban
1
certoparin
1
bemiparin
1
argatroban
1
acarboxyprothrombin
1
abemaciclib
1
Tacrolimus
1
Tablets
1
Surveys and Questionnaires
1
Simvastatin
1
Platelet Transfusion
1
Phenprocoumon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Venous Thromboembolism
×
edoxaban
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts